NCT02843724

Brief Summary

A two year, two arm pragmatic trial to investigate the integration of naturopathic care with conventional medical care to provide additional benefit beyond that of conventional medical care alone in achieving adequate control of diabetes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
148

participants targeted

Target at P75+ for phase_1 diabetes-mellitus-type-2

Timeline
Completed

Started Jul 2016

Longer than P75 for phase_1 diabetes-mellitus-type-2

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

July 14, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 26, 2016

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

July 26, 2016

Status Verified

July 1, 2016

Enrollment Period

2.4 years

First QC Date

July 14, 2016

Last Update Submit

July 21, 2016

Conditions

Keywords

Uncontrolled Type 2 DiabetesHbA1c >7.0%

Outcome Measures

Primary Outcomes (1)

  • Clinically meaningful reduction of HbA1c above and beyond that of control arm

    To assess the integration of naturopathic care to conventional medical care in obtaining a clinically meaningful reduction of HbA1c (equal or \> 0.5%) above and beyond reduction of HbA1c in the control group of phase 1 at 52 week for participants from Wise Elephant Family Health Team (WE-FHT) with type 2 diabetes

    1 year

Secondary Outcomes (22)

  • Incidence of metabolic syndrome

    2 year

  • Weight (as part of BMI)

    2 year

  • Height (as part of BMI)

    2 year

  • Waist circumference (as part of metabolic syndrome)

    2 year

  • Fasting blood glucose

    2 year

  • +17 more secondary outcomes

Study Arms (2)

Control (Conventional) Arm

ACTIVE COMPARATOR

Treatment of Type 2 Diabetes according to the Canadian Diabetes Association guidelines. Participants' other health concerns to be addressed as per usual care by practitioners at Wise-Elephant Family Health Team.

Other: Usual (Conventional) Care

Integrative (Naturopathic + Conventional) Arm

ACTIVE COMPARATOR

In addition to conventional care, participants will receive free naturopathic care at Brampton Naturopathic Teaching Clinic (located within the Brampton Civic Hospital). Senior student clinicians will provide care under the direct supervision of licensed naturopathic doctors. A naturopathic menu of treatment options have been designed to reflect naturopathic practice and vetted by 3 licensed naturopathic doctors and experts in the field. Participants' other health concerns will be addressed as per naturopathic doctors' discretion.

Other: Naturopathic CareOther: Usual (Conventional) Care

Interventions

Naturopathic diabetes care will be selected from a pre-approved menu. Participants' other health concerns will be addressed at naturopathic doctors' discretion

Integrative (Naturopathic + Conventional) Arm

2016 Canadian Diabetes Clinical Practice Guidelines (self-management, blood-glucose-lowering, vascular protection, pharmacotherapy) will be implemented

Control (Conventional) ArmIntegrative (Naturopathic + Conventional) Arm

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males or females, enrolled as a patient with WE-FHT
  • Ages 21-75 years old
  • Diagnosed with type 2 diabetes and not adequately controlled (HbA1c \> 7.0mmol/L)
  • Currently seeking care with a medical doctor, nurse practitioner and/or physician assistant
  • Willingness to adhere to randomized treatment with availability for follow-up
  • Ability to answer self- and interviewer- administered questions in English or have an English speaking caregiver who can aid in answering self- and interviewer- administered questions
  • Ability to provide written informed consent or give informed consent through substitute decision maker
  • Capacity to maintain a diary and log of treatments and recommendations given during study

You may not qualify if:

  • Lacking capacity for consent
  • Pregnancy or an intention to become pregnant in the following two years
  • Breastfeeding
  • History of myocardial infarction within the past 6 months
  • Chronic kidney (eGFR \<30 mL/min) or liver disease
  • Actively receiving care from a complex care diabetes clinic
  • History of severe hypoglycemia in the last year resulting in hospital emergency care \[where hypoglycemia is defined to be: 1) development of autonomic or neuroglycopenic symptoms, 2) low plasma glucose level (\<4.0mmol/L for patients treated with insulin or an insulin secretagogue) and 3) symptoms responding to the administration of carbohydrate\] or hypoglycemia unawareness
  • Current bolus or pre-mixed insulin treatment
  • Limited life expectancy (\< 6 months)
  • High level of functional dependency (inability to perform common activities of daily living)
  • Recent MI or stroke (within last 6 months)
  • NYHA CHF Functional Capacity Stage III or above
  • NYHA CHF Objective Assessment Stage C or greater (http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure\_UCM\_306328\_Article.jsp)
  • Planned revascularization procedure (PCI or coronary artery bypass graft) or coronary angiogram within 90 days after screening or randomization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Wise Elephant Family Health Team

Brampton, Ontario, L6V 4H4, Canada

Location

The Canadian College of Naturopathic Medicine

Toronto, Ontario, M2K 1E2, Canada

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Congresses as Topic

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

OrganizationsHealth Care Economics and Organizations

Study Officials

  • Ellen Wong, ND

    The Canadian College of Naturopathic Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ellen Wong, ND

CONTACT

Kieran Cooley, ND

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Co Principal Investigator

Study Record Dates

First Submitted

July 14, 2016

First Posted

July 26, 2016

Study Start

July 1, 2016

Primary Completion

December 1, 2018

Study Completion

July 1, 2019

Last Updated

July 26, 2016

Record last verified: 2016-07

Data Sharing

IPD Sharing
Will not share

Locations